ReviewAntioxidants (Basel, Switzerland)2020

Thioredoxin and Glutaredoxin Systems as Potential Targets for the Development of New Treatments in Friedreich's Ataxia.

Marta Seco-Cervera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.